HUP0100957A2 - [(5-Szubsztituált-2-pirimidinil)-oxi]-karbonsav-származékok, előállításuk, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
[(5-Szubsztituált-2-pirimidinil)-oxi]-karbonsav-származékok, előállításuk, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0100957A2 HUP0100957A2 HU0100957A HUP0100957A HUP0100957A2 HU P0100957 A2 HUP0100957 A2 HU P0100957A2 HU 0100957 A HU0100957 A HU 0100957A HU P0100957 A HUP0100957 A HU P0100957A HU P0100957 A2 HUP0100957 A2 HU P0100957A2
- Authority
- HU
- Hungary
- Prior art keywords
- production
- carboxylic acid
- pharmaceutical compositions
- same
- compositions containing
- Prior art date
Links
- -1 5-substituted pyrimidine-2-yloxy carboxylic acid Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19806438A DE19806438A1 (de) | 1998-02-17 | 1998-02-17 | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| PCT/EP1999/000776 WO1999042453A1 (de) | 1998-02-17 | 1999-02-05 | 5-substituierte pyrimidin-2-yloxy-carbonsäurederivate, deren herstellung und deren verwendung als endothelin-antagonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0100957A2 true HUP0100957A2 (hu) | 2002-02-28 |
| HUP0100957A3 HUP0100957A3 (en) | 2002-03-28 |
Family
ID=7857948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100957A HUP0100957A3 (en) | 1998-02-17 | 1999-02-05 | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same, their use and pharmaceutical compositions containing them |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1066268A1 (hu) |
| JP (1) | JP2002503726A (hu) |
| KR (1) | KR20010086247A (hu) |
| CN (1) | CN1291190A (hu) |
| AR (1) | AR014960A1 (hu) |
| AU (1) | AU3027199A (hu) |
| BG (1) | BG104577A (hu) |
| BR (1) | BR9907911A (hu) |
| CA (1) | CA2321182A1 (hu) |
| DE (1) | DE19806438A1 (hu) |
| HR (1) | HRP20000602A2 (hu) |
| HU (1) | HUP0100957A3 (hu) |
| IL (1) | IL137038A0 (hu) |
| NO (1) | NO20004075L (hu) |
| PL (1) | PL342311A1 (hu) |
| SK (1) | SK11512000A3 (hu) |
| TR (1) | TR200002376T2 (hu) |
| TW (1) | TW579376B (hu) |
| WO (1) | WO1999042453A1 (hu) |
| ZA (1) | ZA991214B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| MX2010001255A (es) * | 2007-07-31 | 2010-12-06 | Gilead Colorado Inc | Metabolitos y derivados de ambrisentan. |
| BRPI0907435A8 (pt) * | 2008-01-22 | 2019-01-29 | Dow Agrosciences Llc | derivados de 5-flúor pirimidina |
| WO2010047866A2 (en) * | 2008-08-01 | 2010-04-29 | Dow Agrosciences Llc | Use of 5-fluorocytosine as a fungicide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614533A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
| DE19614534A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| BR9714047A (pt) * | 1996-12-18 | 2000-05-09 | Basf Ag | Derivados de ácido carboxìlico, uso dos mesmos, combinação destes com um ou mais compostos ativos, preparação de drogas para a administração oral e parenteral, e, antagonista de receptor de endotelina |
| DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| ID24278A (id) * | 1997-10-31 | 2000-07-13 | Basf Ag | Turunan-turunan asam karboksilat baru dengan rantai sisi amida, pembuatan dan penggunaannya sebagai reseptor antagonis endotelin |
-
1998
- 1998-02-17 DE DE19806438A patent/DE19806438A1/de not_active Withdrawn
-
1999
- 1999-02-05 JP JP2000532405A patent/JP2002503726A/ja active Pending
- 1999-02-05 EP EP99911657A patent/EP1066268A1/de not_active Withdrawn
- 1999-02-05 WO PCT/EP1999/000776 patent/WO1999042453A1/de not_active Application Discontinuation
- 1999-02-05 TR TR2000/02376T patent/TR200002376T2/xx unknown
- 1999-02-05 KR KR1020007008925A patent/KR20010086247A/ko not_active Application Discontinuation
- 1999-02-05 PL PL99342311A patent/PL342311A1/xx unknown
- 1999-02-05 SK SK1151-2000A patent/SK11512000A3/sk unknown
- 1999-02-05 HU HU0100957A patent/HUP0100957A3/hu unknown
- 1999-02-05 BR BR9907911-9A patent/BR9907911A/pt not_active IP Right Cessation
- 1999-02-05 CN CN99803037A patent/CN1291190A/zh active Pending
- 1999-02-05 IL IL13703899A patent/IL137038A0/xx unknown
- 1999-02-05 CA CA002321182A patent/CA2321182A1/en not_active Abandoned
- 1999-02-05 AU AU30271/99A patent/AU3027199A/en not_active Abandoned
- 1999-02-10 TW TW088102031A patent/TW579376B/zh active
- 1999-02-16 AR ARP990100634A patent/AR014960A1/es not_active Application Discontinuation
- 1999-02-16 ZA ZA9901214A patent/ZA991214B/xx unknown
-
2000
- 2000-07-04 BG BG104577A patent/BG104577A/bg unknown
- 2000-08-15 NO NO20004075A patent/NO20004075L/no not_active Application Discontinuation
- 2000-09-13 HR HR20000602A patent/HRP20000602A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20000602A2 (en) | 2001-06-30 |
| WO1999042453A1 (de) | 1999-08-26 |
| HUP0100957A3 (en) | 2002-03-28 |
| TW579376B (en) | 2004-03-11 |
| CN1291190A (zh) | 2001-04-11 |
| JP2002503726A (ja) | 2002-02-05 |
| EP1066268A1 (de) | 2001-01-10 |
| NO20004075D0 (no) | 2000-08-15 |
| AU3027199A (en) | 1999-09-06 |
| BG104577A (bg) | 2001-03-30 |
| SK11512000A3 (sk) | 2001-04-09 |
| IL137038A0 (en) | 2001-06-14 |
| PL342311A1 (en) | 2001-06-04 |
| ZA991214B (en) | 2000-08-16 |
| DE19806438A1 (de) | 1999-08-19 |
| TR200002376T2 (tr) | 2000-12-21 |
| NO20004075L (no) | 2000-08-15 |
| KR20010086247A (ko) | 2001-09-10 |
| AR014960A1 (es) | 2001-04-11 |
| BR9907911A (pt) | 2000-10-24 |
| CA2321182A1 (en) | 1999-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200312A3 (en) | Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use | |
| IL145732A0 (en) | α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0204373A3 (en) | Carboxylic acid amides, pharmaceutical compositions containing these compounds and the use and production thereof | |
| HUP0102766A3 (en) | Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them | |
| HUP0004225A3 (en) | Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
| HUP0203190A3 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| EP1216980A4 (en) | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME | |
| IL138969A0 (en) | Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL140498A0 (en) | Phenoxyacetic acid derivatives and medicinal compositions containing the same | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0204143A3 (en) | Tricyclic 1-benzylpyrazole-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them | |
| HUP0103165A3 (en) | Thiazoline acid derivatives, pharmaceutical compositions containig the same and their use | |
| HUP0105073A3 (en) | 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them | |
| EP1311477A4 (en) | NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM | |
| HUP9901616A3 (en) | Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same | |
| PL347105A1 (en) | Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof | |
| AU5647199A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| IL136612A (en) | Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
| HU9700955D0 (en) | Substituted 2-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them | |
| IL159084A0 (en) | Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0000084A3 (en) | 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them | |
| HUP0300295A3 (en) | Substituted benzamide derivatives, pharmaceutical compositions containing them and their use | |
| AU5443499A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| HUP0000553A3 (en) | Sixmembered nitrogencontained heteroaromatic carboxylic acid derivatives, pharmaceutical compositions containing them, and their use for producing pharmaceutical compositions |